Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
The drug is in the form of an oral capsule and should be taken in the morning for one capsule daily
Gently swirl until the contents are fully dissolved
Weight loss effects vary by population, with approximately 5-11% in diabetes trials and 15-21% in obesity trials (SURMOUNT program) at the highest doses
Eli Lilly plans to begin orforgliprons review process for regulatory approval for weight loss in 2025 and for type 2 diabetes in 2026
Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the Kras(G12D) Mouse Model
While exercise is beneficial for diabetes management and weight loss, patients should avoid sudden intense exertion during the first weeks of therapy or after dose increases
US$ 21.95
US$ 23.19
US$ 27.26
US$ 26.34
